Clinical Trials
Fujitsu Launches Major Initiative to Attract Global Clinical Trials to Japan, Tackling the Nation's 'Drug Loss' Issue
Fujitsu announced that it will begin initiatives to attract global clinical trials to Japan and tackle the ‘drug loss’ issue by working w...
August 26, 2024 | News
Mabwell Receives NMPA Approval to Initiate Phase III Study of 9MW2821 in Recurrent or Metastatic Cervical Cancer
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (C...
August 26, 2024 | News
CanariaBio Completes Enrollment for Phase 2 Study of Oregovomab with Chemotherapy in Advanced Ovarian Cancer
CanariaBio Inc, a leading late-stage biotechnology company, announces the successful completion of enrollment of 88 patients in a randomized Phase 2 study ...
August 26, 2024 | News
AiViva Biopharma Completes Enrollment in Phase 1 Trial of AIV007 for Wet AMD and DME
AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has fully enrolled and completed dosing the last patient in a Phase 1 tria...
August 26, 2024 | News
Everest Medicines Launches First Clinical Trial for Personalized mRNA Cancer Vaccine EVM16 in China
Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeut...
August 22, 2024 | News
CARsgen Therapeutics Completes Enrollment in Pivotal Phase II Trial of Satri-Cel for Advanced Gastric Cancer in China
CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...
August 20, 2024 | News
Astellas Pharma Gains NMPA Approval for PADCEV™ in China to Treat Advanced Urothelial Cancer
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that the Center for Drug Evaluation (CDE) of C...
August 20, 2024 | News
Pfizer and BioNTech Announce Mixed Results from Phase 3 Trial of Combination mRNA Vaccine for Influenza and COVID-19
Pfizer Inc. and BioNTech SE announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vac...
August 19, 2024 | News
Noxopharm Targets First-in-Human Clinical Trial for First-in-Class Drug SOF-SKN™
Highlights: First-in-human clinical trial for SOF-SKN™ and Sofra™ platform Efficient trial design with early results expected Le...
August 19, 2024 | News
Boston Immune Technologies and Therapeutics Secures Strategic Agreement with Otsuka's MSRD and $4M NIH/NCI Grant for Advancing Antibody Development
Boston Immune Technologies and Therapeutics, Inc. (BITT), a clinical stage developer of novel tumor necrosis factor superfamily receptor (TNFSR) antagonist...
August 19, 2024 | News
Vimgreen Pharmaceuticals Completes Enrollment for Phase 2 Trial of Novel A2A Receptor Antagonist in Parkinson's Disease
Vimgreen Pharmaceuticals, a science-driven pharmaceutical company focused on the modulation of adenosine signaling, announced the completion of enrollment ...
August 16, 2024 | News
Alfred Health Expands Oracle EHR to Enhance Cancer Care and Clinical Trial Access
Leading Victorian healthcare network, Alfred Health, has extended its long-standing Oracle Health footprint with Oracle's Oncology electroni...
August 14, 2024 | News
Mabwell's Nectin-4 Targeting ADC Receives Breakthrough Therapy Designation in China for Urothelial Carcinoma
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel Nectin-4 targeting ADC (R&D code: 9MW2821)...
August 13, 2024 | News
Lynk Pharmaceuticals Reports Positive Phase 1b Results for Skin-Restricted JAK Inhibitor LNK01004 in Atopic Dermatitis Treatment
Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, announced positiv...
August 13, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
